Arrhythmia Monitoring Devices Market by Product and Geography - Forecast and Analysis 2021-2025

The arrhythmia monitoring devices market share is expected to increase by USD 2.79 billion from 2021 to 2025, and the market's growth momentum will accelerate at a CAGR of 8%.

This arrhythmia monitoring devices market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (ECG and Holter monitors, implantable cardiac monitors, and cardiac event monitors) and geography (North America, Europe, ROW, and Asia). The arrhythmia monitoring devices market report also offers information on several market vendors, including Abbott Laboratories, AliveCor Inc., BioTelemetry Inc., BIOTRONIK SE & Co. KG, B-Secur Ltd., CardioComm Solutions Inc., General Electric Co., Hillrom, Koninklijke Philips NV, and Medtronic Plc, among others.

What will the Arrhythmia Monitoring Devices Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Arrhythmia Monitoring Devices Market Size for the Forecast Period and Other Important Statistics

Arrhythmia Monitoring Devices Market: Key Drivers and Challenges

Based on our research output, there has been a positive impact on the market growth during and post the COVID-19 era. The growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases is notably driving the arrhythmia monitoring devices market growth, although factors such as high costs associated with arrhythmia monitoring devices may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic's impact on the arrhythmia monitoring devices market industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Arrhythmia Monitoring Devices Market Driver

The growing number of cardiac cases related to the irregularity in heart rhythms and structural heart diseases is boosting the demand for arrhythmia monitoring devices. Ventricular fibrillation leads the heart's lower chamber to stop beating and pumping blood to the body. This can lead to arrhythmia, causing cardiac arrest. With the increasing number of structural heart diseases and the irregularity in heart rhythms and other conditions, there is a growing demand for arrhythmia monitoring devices. 

Key Arrhythmia Monitoring Devices Market Challenge

The high cost of arrhythmia monitoring devices and procedures can affect the adoption of arrhythmia monitoring devices. Moreover, few countries provide reimbursement for arrhythmia procedures, which has negatively affected market growth. In developing countries such as India and China, there is no government reimbursement for such procedures. Patients must depend on private insurance companies. The average cost of arrhythmia monitoring devices differs based on product types. Thus, high arrhythmia monitoring procedure cost and limited or no reimbursement has led patients to opt for other substitutes such as pulse oximeters, thereby affecting the growth of the market.

This arrhythmia monitoring devices market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Who are the Major Arrhythmia Monitoring Devices Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

• Abbott Laboratories
• AliveCor Inc.
• BioTelemetry Inc.
• BIOTRONIK SE & Co. KG
• B-Secur Ltd.
• CardioComm Solutions Inc.
• General Electric Co.
• Hillrom
• Koninklijke Philips NV
• Medtronic Plc

This statistical study of the arrhythmia monitoring devices market encompasses successful business strategies deployed by the key vendors. The arrhythmia monitoring devices market is fragmented, and the vendors are deploying growth strategies such as mergers and acquisitions to compete in the market.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The arrhythmia monitoring devices market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Arrhythmia Monitoring Devices Market?